Stunning Trump Policy Unlocks Upfront Cash Payouts

The U.S. has collected $15B from Trump's tariffs - and now, thanks to Title 15, you could claim your own $100-$1,000 instant upfront cash payouts. No stocks needed. Use your phone and this income technique to collect upfront payouts now.

Can AI Solve Cannabis Medicine's Data Problem? New Tech Initiative Aims To Streamline Research And Treatments

Javier Hasse
January 16, 2025

Kanavos Inc. has announced a strategic partnership with Graphwise, a global leader in semantic AI technologies, and HomeLab, a prominent biotech accelerator based at UC San Diego, to develop the Cannabis Knowledge Graph.

Graphwise, known for its expertise in creating advanced knowledge graph solutions, brings a deep understanding of data organization and AI-powered insights, making it an ideal partner for this initiative. HomeLab, a key player in fostering biotech innovation, has supported more than 50 startups and helped raise more than $1.5 billion in funding, positioning it as a trusted hub for life sciences innovation.

The Cannabis Knowledge Graph, aimed at providing patients and healthcare providers with accessible, evidence-based insights into cannabinoid therapies, was unveiled this week in San Francisco, coinciding with the J.P. Morgan Healthcare Conference taking place in the city. This announcement represents a significant step toward addressing the fragmented state of cannabis research and empowering more informed treatment decisions.

A New Approach To Cannabis Medicine

The Cannabis Knowledge Graph is still under development, but its goals are clear: to provide cannabis patients a unified source to discover scientific evidenced based therapeutics empowering personalized actionable decisions, consolidate clinical trials, preclinical research and real-world evidence into a unified resource. By leveraging Graphwise's Semantic AI technology, Kanavos aims to create a tool that provides actionable, personalized insights to patients and providers navigating cannabinoid-based medicine.

At its core, a knowledge graph is a data structure that organizes information by mapping relationships between entities. In the context of cannabis medicine, this means connecting diverse data sources—such as scientific evidence-based research with provenance, clinical trials, and patient outcomes—to reveal meaningful patterns and actionable insights. Unlike traditional databases, which simply store information, a Semantic AI knowledge graph enables AI systems to interpret and understand the meaning behind human language, concepts and data. This allows for a deeper understanding of how data points are interconnected, making it particularly valuable for complex fields like healthcare.

"This partnership with Graphwise marks a significant milestone for patients seeking to leverage the therapeutic potential of cannabinoids," said Dr. Deborah McGuinness, chief knowledge officer at Kanavos. "By combining our deep domain expertise with Graphwise's leading-edge technology, we are empowering individuals with the knowledge and insights they need to make informed healthcare decisions."

Addressing Critical Industry Challenges

The fragmented nature of cannabis research has long been a challenge for patients and providers. The Cannabis Knowledge Graph seeks to address this by organizing and contextualizing data, enabling users to compare therapeutic options and make more informed decisions. Unlike generative AI tools, the platform focuses on understanding relationships in data to deliver meaningful insights.

"By connecting disparate data sources – from Open LinkedLife Data to 80 million research publications, clinical trials to real-world evidence with provenance – we can unlock invaluable insights and empower patients with the information they need to make informed healthcare decisions," said Antanas Kiryakov, president of Graphwise.

The Road Ahead

Kanavos’ partnerships include licenses for adult-use cannabis and DEA Schedule 1 drug manufacturing for research and development, positioning the company to explore novel therapeutic applications for cannabinoids as the Cannabis Knowledge Graph takes shape. This initiative is part of a broader trend of applying advanced semantic AI technologies to life sciences, healthcare and the wellness industries. The goal is to legitimize and expand the use of cannabinoids in therapeutic settings through rigorous data integration and actionable insights.

By building this platform, Kanavos is contributing to the broader adoption of data-driven solutions in healthcare. The company's collaborations with Graphwise and HomeLab aim to address challenges in cannabis research and facilitate advancements in cannabinoid-based medicine.

Cover image made with AI

Continue Reading...

Popular

Trump keeps saying the GOP mega bill will eliminate taxes on Social Security. It does not

WASHINGTON (AP) — President keeps saying that Republicans' mega legislation will eliminate taxes on federal benefits.

A judge resisted Trump’s order on gender identity. The EEOC just fired her

The federal agency charged with protecting workers’ civil rights has terminated a New York administrative judge who , including President Donald Trump’s executive order decreeing male and female as .

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.

Once known as 'Dirty Myrtle,' Myrtle Beach is now the fastest-growing US metro for seniors

A South Carolina beach town once nicknamed “Dirty Myrtle” because of its rowdy nightclubs and strip joints has become a magnet for retirees in a nation that continues to age.

Cathie Wood Dumps Jack Dorsey's Block As Bitcoin Flirts With All-Time Highs, Bets $8.8 million On Tempus AI

On Wednesday, the Cathie Wood-led Ark Invest made a significant move by purchasing a substantial number of shares in Tempus AI Inc. (NASDAQ:TEM) and selling shares of Block Inc. (NYSE:XYZ).

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

These are the celebs who are attending Jeff Bezos’ Venice wedding

VENICE, Italy (AP) — arrived in Venice on Thursday, leading a star-studded guest list of celebrities descending on the lagoon city for the weekend wedding of Amazon founder Jeff Bezos and Lauren Sánchez.

After Diddy's conviction, here's where his business ventures stand

LOS ANGELES (AP) — Sean “Diddy” Combs has been in his federal sex trafficking trial, but that doesn't mean the once-celebrated music mogul will see his business empire restored.

What's inside Elon's building in Memphis will shock you - Ad

Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the July 1st funding window closes.

FDA requires updated warning about rare heart risk with COVID shots

WASHINGTON (AP) — said Wednesday it has expanded existing warnings on the two leading COVID-19 vaccines about a rare heart side effect mainly seen in young men.

FACT FOCUS: No, weather modification did not cause the deadly flash floods in Texas

As authorities search for victims of the in Texas that killed more than 100 people over the Fourth of July holiday weekend, social media users are spreading false claims that the devastation was caused by weather modification.

Elon's Greatest Invention... Hidden in South Memphis? - Ad

In South Memphis, I uncovered what could be Elon Musk's biggest invention yet. It's so secretive, rivals are flying drones to spy on it. If you're serious about investing in AI, now's the time to see what's really going on inside those walls.

Greenland has a message for the rest of the world: Come visit

NUUK, Greenland (AP) — has a message for the rest of the world: We’re waiting for you.

Is This Defense AI Stock The Next Palantir? It's Starting To Look That Way

BigBear.ai (BBAI) is gaining momentum with a $165 million defense contract and its AI platform being featured in a U.S. Army project, making it an appealing option compared to Palantir's high valuation.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

Benzinga Bulls And Bears: Datadog, Centene, Lucid — And US Makes Surprise Trade Deal With Vietnam

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

A hard-right lawmaker is sworn in as Greece's migration minister

ATHENS, Greece (AP) — A hard-right lawmaker was sworn in Monday as Greece’s migration minister, replacing a fellow right-wing political heavyweight who resigned following

Do These 4 Things to Your Bank Account Now ... - Ad

A sweeping U.S. policy could soon let the government track-or even freeze-your bank account. But there are 4 simple steps you can take right now to protect your savings before it's potentially too late.

How to manage ADHD at work and turn it into a strength

NEW YORK (AP) — Jeremy Didier had taken her son to a psychologist for a when she spotted an article about women with the condition. As she read it in the waiting room, she thought to herself: They're describing me.

UnitedHealthcare Group, Gryphon Digital Mining, AMC Entertainment, Centene, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

Major U.S. indices were mixed on Tuesday, with the Dow Jones Industrial Average rising 0.9% to 44,494.94 and the S&P 500 declining 0.1% to 6,198.01. The Nasdaq fell 0.8% to 20,202.89. These are the top stocks that gained the attention of retail traders and investors throughout the day:

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after July 23rd, it may be too late.

What to Stream: Ryan Coogler’s 'Sinners,' a Kesha album, 'SharkFest' and John Cena with Idris Elba

Kesha enjoying her freedom on her first new album since she left her old label and Ryan Coogler’s guts-spilling vampire film “Sinners,” are some of the new television, films, music and games near you.

Trump's Crypto Ventures, Draper And Cathie Wood's Bitcoin Predictions, MSTR Estimates, And More: This Week In Crypto

The past week in the world of cryptocurrency was nothing short of eventful. From legislative moves aimed at curbing alleged corruption in cryptocurrency ventures to bold predictions about Bitcoin’s dominance, the week was filled with intriguing developments. Here’s a quick recap of the top stories that made headlines.

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

ExxonMobil and partner Qatar Energy find new natural gas deposit off Cyprus

NICOSIA, Cyprus (AP) — A consortium made up of ExxonMobil and partner Qatar Energy International has made a second natural gas discovery beneath the seabed south of , the government said Monday, a find that bolsters the region’s potential as an energy exporter.

A 64% Dividend From Gold? - Ad

Gold is soaring. But here's what no one's talking about: a way to earn a 64% dividend-paid in real cash every 30 days. No trading. No risky mining stocks. Just one simple move in your brokerage account... and you could start collecting monthly income almost instantly.

Women can be drafted into the Danish military as Russian aggression and military investment grows

HOVELTE, Denmark (AP) — Peering across a dense stretch of woodland outside of Denmark's capital with camouflage paint smeared across her face, 20-year-old Katrine scans the horizon for approaching threats.

Stunning Trump Policy Unlocks Upfront Cash Payouts - Ad

The U.S. has collected $15B from Trump's tariffs - and now, thanks to Title 15, you could claim your own $100-$1,000 instant upfront cash payouts. No stocks needed. Use your phone and this income technique to collect upfront payouts now.

Apple Has the Potential To Crush Meta's Ray-Ban Smart Glasses, Says Ming-Chi Kuo, But The Tech Giant Has Been 'Surprisingly Slow'

Analyst Ming-Chi Kuo believes Apple has the potential to surpass Meta's Ray-Ban smart glasses, but notes the company's slow progress in this market could delay its dominance.

Elon Musk Says 'Clear Path' To Restoring Hearing With Neuralink, But The Deaf Community Want To Have Their 'Say'

Elon Musk's Neuralink faces backlash from the deaf community after proposing brain implant technology to restore hearing, with deaf adults calling for inclusion in the research process.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.

Trump vents online about service provider after conference call marred by glitch

WASHINGTON (AP) — On Monday afternoon, the president of the United States was just another person complaining online about his service provider.

Big Banks Pass Fed's 2025 Stress Test With Ease—But Some Say It Was Too Easy

All major U.S. banks passed the Fed's 2025 stress test, but critics say easier assumptions may have padded the results.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Trump's Approval Ratings, Tariff Deadlines, Schumer's Criticism, And Defense Budget Shifts: This Week In Politics

Trump's approval ratings drop after Iran attack, hints at tariff deadline flexibility. SC limits judges' power, Schumer criticizes GOP budget, defense budget shifts to missiles and drones.

Apple Sues Ex-Engineer Over Alleged Theft Of Vision Pro Secrets As Snap Prepares AR Glasses Launch

Apple files lawsuit accusing former senior design engineer of stealing confidential information before leaving to work at Snap.

What's inside Elon's building in Memphis will shock you - Ad

Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the July 1st funding window closes.

US brings charges in North Korean remote worker scheme that officials say funds weapons program

WASHINGTON (AP) — The Justice Department announced criminal charges Monday in connection with a scheme by North Korea to fund its weapons program through the salaries of remote information technology workers employed unwittingly by U.S. companies.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service